These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7559008)

  • 1. Review of the first interactive workshop on professional flexible labeling. An American Veterinary Medical Association perspective.
    Papich MG
    J Am Vet Med Assoc; 1995 Oct; 207(7):871-4. PubMed ID: 7559008
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of the first interactive workshop on professional flexible labeling. An Animal Health Institute perspective.
    Farho CJ
    J Am Vet Med Assoc; 1995 Oct; 207(7):869-71. PubMed ID: 7559007
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of the first interactive workshop on professional flexible labeling. The Center for Veterinary Medicine perspective.
    Sundlof SF
    J Am Vet Med Assoc; 1995 Oct; 207(7):867-8. PubMed ID: 7559006
    [No Abstract]   [Full Text] [Related]  

  • 4. American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part I.
    Koritz GD
    J Am Vet Med Assoc; 1995 Oct; 207(7):875-6. PubMed ID: 7559009
    [No Abstract]   [Full Text] [Related]  

  • 5. American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part II.
    Riviere JE
    J Am Vet Med Assoc; 1995 Oct; 207(7):876-8. PubMed ID: 7559010
    [No Abstract]   [Full Text] [Related]  

  • 6. Extra-label drug use: with rights come responsibilities.
    Cleland JL
    J Am Vet Med Assoc; 1996 Sep; 209(5):897-8. PubMed ID: 8790533
    [No Abstract]   [Full Text] [Related]  

  • 7. AHI perspectives: flexible drug labeling and its impact on the drug development process. Liability issues.
    Thomas JW
    J Am Vet Med Assoc; 1995 Oct; 207(7):899-900; discussion 902-4. PubMed ID: 7559021
    [No Abstract]   [Full Text] [Related]  

  • 8. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Swine Practitioners (AASP).
    Waddell JT
    J Am Vet Med Assoc; 1995 Oct; 207(7):887; discussion 890-4. PubMed ID: 7559016
    [No Abstract]   [Full Text] [Related]  

  • 9. Flexible labeling, streamlined drug approval advocated at workshop.
    Raef TA
    J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
    [No Abstract]   [Full Text] [Related]  

  • 10. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Bovine Practitioners (AABP).
    Riddell MG
    J Am Vet Med Assoc; 1995 Oct; 207(7):882-3; discussion 890-4. PubMed ID: 7559013
    [No Abstract]   [Full Text] [Related]  

  • 11. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Small Ruminant Practitioners (AASRP).
    Matthews DM
    J Am Vet Med Assoc; 1995 Oct; 207(7):885-6; discussion 890-4. PubMed ID: 7559015
    [No Abstract]   [Full Text] [Related]  

  • 12. AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Equine Practitioners (AAEP).
    White NA
    J Am Vet Med Assoc; 1995 Oct; 207(7):884-5; discussion 890-4. PubMed ID: 7559014
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination issues of concern to practitioners.
    Hustead DR; Carpenter T; Sawyer DC; Bain FT; Henry SC; Huxsol DL; Klingborg DJ; McKissick GE; McNutt RL; Niles DE; Short CR
    J Am Vet Med Assoc; 1999 Apr; 214(7):1000-2. PubMed ID: 10200790
    [No Abstract]   [Full Text] [Related]  

  • 14. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 15. Talks bridge AVMA, AAVSB relations, but not dual programs. American Veterinary Medical Association. American Association of Veterinary State Boards.
    Kahler SC
    J Am Vet Med Assoc; 2002 Apr; 220(7):947-8. PubMed ID: 12420762
    [No Abstract]   [Full Text] [Related]  

  • 16. AVMA Washington office commended for courage, professionalism. American Veterinary Medical Association.
    Donathan R
    J Am Vet Med Assoc; 2001 Dec; 219(12):1677. PubMed ID: 11767914
    [No Abstract]   [Full Text] [Related]  

  • 17. A step closer to reality: professional flexible labeling for animal drugs.
    Gloyd JS
    J Am Vet Med Assoc; 1996 Feb; 208(4):457-9. PubMed ID: 8603883
    [No Abstract]   [Full Text] [Related]  

  • 18. The issue of extralabel drug use.
    Kennedy JA
    J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
    [No Abstract]   [Full Text] [Related]  

  • 19. AVMA guidelines on compounding.
    Upson D
    J Am Vet Med Assoc; 1994 Jul; 205(2):199-200. PubMed ID: 7928573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AHI perspectives: flexible drug labeling and its impact on the drug development process. Practicality of clinical development.
    Copeland DD
    J Am Vet Med Assoc; 1995 Oct; 207(7):895-6; discussion 902-4. PubMed ID: 7559018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.